Folinezuur Sandoz 10 mg/ml

DRUG3 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Conditions

Non-metastatic resectable pancreatic cancercolorectal adenocarcinomanon-metastatic (borderline) resectable pancreatic cancer

Phase 2

Hepatic arterial infusion PUMP chemotherapy combined with systemIc chemoTherapy for potentially resectable colorectal liver metastases. - The PUMP-IT study (M19PIT)

Active, not recruitingCTIS2024-515525-28-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichtingcolorectal adenocarcinoma

Start: 2020-09-10Target: 31Updated: 2024-11-27

Phase 3

Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study

Not yet recruitingCTIS2024-510617-15-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Non-metastatic resectable pancreatic cancer

Target: 378Updated: 2024-09-09

THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

Not yet recruitingCTIS2024-516260-29-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)non-metastatic (borderline) resectable pancreatic cancer

Target: 368Updated: 2024-10-09